Management has invested behind organic growth (branch builds in the Southeast, technology, analytics) while balancing distributions. In 2025 the company returned about 1.6 billion dollars to shareholders and paused repurchases late in the year ahead of the Comerica deal.
The board refreshed a large repurchase authorization in June 2025 and executed ASR programs earlier in the year; average repurchase price was around 43.46 dollars in 2025. The February 2026 all‑stock merger with Comerica adds scale and strategic adjacency but also brings integration execution risk and share issuance dilution.
Payments and data‑adjacent tuck‑ins (for example, DTS Connex, Big Data Healthcare) fit the fee‑mix strategy. Overall discipline appears solid, but we haircut for the integration risk and the limits banks face on capital returns as they migrate to stricter capital and liquidity regimes.







